drugset / Trial / NCT06160427

Connective Tissue Matrix for Rotator Cuff Tendinopathy

NCT06160427

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.

Timeline

Start
2023-12-04
Primary completion
2027-01-15
Completion
2028-01-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CTM Boost Other / unclassified 2 ml Other
Comparator Platelet Rich Plasma Other / unclassified 5 ml Other

Indications